Correlation Between Aeterna Zentaris and Ocuphire Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aeterna Zentaris and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aeterna Zentaris and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aeterna Zentaris and Ocuphire Pharma, you can compare the effects of market volatilities on Aeterna Zentaris and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aeterna Zentaris with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aeterna Zentaris and Ocuphire Pharma.

Diversification Opportunities for Aeterna Zentaris and Ocuphire Pharma

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aeterna and Ocuphire is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Aeterna Zentaris and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Aeterna Zentaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aeterna Zentaris are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Aeterna Zentaris i.e., Aeterna Zentaris and Ocuphire Pharma go up and down completely randomly.

Pair Corralation between Aeterna Zentaris and Ocuphire Pharma

If you would invest  113.00  in Ocuphire Pharma on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Ocuphire Pharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aeterna Zentaris  vs.  Ocuphire Pharma

 Performance 
       Timeline  
Aeterna Zentaris 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aeterna Zentaris has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Aeterna Zentaris is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Ocuphire Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocuphire Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Ocuphire Pharma is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Aeterna Zentaris and Ocuphire Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aeterna Zentaris and Ocuphire Pharma

The main advantage of trading using opposite Aeterna Zentaris and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aeterna Zentaris position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.
The idea behind Aeterna Zentaris and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets